With pharma investing heavily in cell-based research and drug development, it is becoming imperative to take extra precautions in maintaining temperature stability. Although recognition is widespread, efforts to standardize processes are still in their early days. However, the technology involved with controlled-rate cell freezing has seen significant updates in recent years.
Fill out the form to download the full article and learn more about the innovative temperature standardization solutions supporting pharma research!
